---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-029560"
form_type: "8-K"
ticker: "PRPL"
cik: "0001643953"
company_name: "Purple Innovation, Inc."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:39:59.425542+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Purple settles proxy fight with Coliseum; board adds 3 new directors, redeems preferred stock, ends poison pill

## Summary
- Board expands to 8; Paul Zepf and Pano Anthos resign; Adam Gray becomes Chair; Gary DiCamillo remains Lead Independent Director.
- Coliseum nominees Hoby Darling, Carter Pate, and Erika Serow join board; Scott Peterson added to slate for 2023 annual meeting.
- Purple will redeem Proportional Representation Preferred Linked Stock and terminate September 2022 stockholder rights agreement (poison pill).
- Coliseum drops litigation, agrees to standstill through 2024 annual meeting and not to exceed 44.7% ownership, subject to exceptions.
- Company to reimburse Coliseum up to $4M in legal fees; 2023 annual meeting to be held by June 16, 2023.

## SEC filing metadata
- accession: 0001213900-23-029560
- form_type: 8-K
- ticker: PRPL
- cik: 0001643953
- company_name: Purple Innovation, Inc.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1643953/000121390023029560/0001213900-23-029560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1643953/000121390023029560/ea176891-8k_purple.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-029560
- JSON: https://secwatch.observer/filing/0001213900-23-029560.json
- Plain text: https://secwatch.observer/filing/0001213900-23-029560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.